3rd Annual

mRNA CONFERENCE EUROPE 2026

|


view programarrow icon

Discover the highlights of the event

connect with usarrow icon

Get your questions answered by our team

become a partnerarrow icon

Join as a sponsor and reserve your booth

Meet Our Featured Speakers

Bernhard Bobusch

Bernhard Bobusch

FDX Fluid Dynamix GmbH

Close icon
Rok Sekirnik

Rok Sekirnik

BIA Separations

Bernhard Bobusch

Bernhard Bobusch

FDX Fluid Dynamix GmbH

Davide De Lucrezia

Davide De Lucrezia

Officinae Bio

THE PREMIER FORUM FOR mRNA-BASED THERAPEUTICS AND DRUG DEVELOPMENT

Welcome to the European mRNA Conference 2026, where global pharmaceutical and biotechnology leaders meet industry experts to explore innovations in mRNA therapeutics for vaccines, personalised medicine, and beyond.

This event explores the role of mRNA technology in developing novel treatments, covering research and development, clinical trials, large-scale manufacturing, and commercialisation. It highlights advances in RNA modification, therapeutic delivery systems, and vaccine development, showcasing the latest progress in mRNA medicine and oligonucleotide therapeutics.

Join us to explore next-generation mRNA therapeutics, gain valuable insights, and work together to shape the future of medicine.

key topics for

Future of mRNA-based therapeutics in infectious diseases and other areas

Explore the potential of mRNA therapeutics as a revolutionary new class of drugs.

Breakthrough research on mRNA medicines and oligonucleotide therapeutics

Understand how the latest developments in mRNA medicine and oligonucleotide therapeutics are transforming the advanced therapies industry worldwide.

Manufacturing challenges in global mRNA vaccine production

Examine cutting-edge strategies for the rapid development and large-scale deployment of vaccines to effectively respond to global pandemics.

Latest advancements in mRNA formulation and delivery technologies

Learn about the latest technological advancements in therapeutic mRNA delivery, tracing the journey from laboratory research to successful clinical application.

Data-driven strategies using AI and ML in mRNA therapeutic design

Discover how advanced AI and ML algorithms, supported by powerful data analytics, are accelerating therapeutic design and revealing novel biomedical insights.

Regulatory and compliance considerations in mRNA clinical development

Grasp key regulatory and commercial considerations shaping the approval pathway of mRNA therapeutics.

0

INDUSTRY TOPICS

0

NETWORKING EVENTS

0

LEADING EXPERTS

0

Q&A SESSIONS

Latest News

  • REGULATORY

    12 Feb 2026

    mRNA Makers Face a More Exacting Europe
  • INNOVATION

    6 Feb 2026

    From Concept to Clinic, Circular RNA Faces Its Test
  • TECHNOLOGY

    4 Feb 2026

    Algorithms Are Now Europe’s Hottest Biotech Talent
  • PARTNERSHIPS

    8 Dec 2025

    Can BioNTech’s CureVac Deal Spark a Biotech Revival?

A Power Partnership Pushes Europe’s mRNA Ambitions

Thermo Fisher Scientific logo as company partners on mRNA development

PARTNERSHIPS

3 Dec 2025

Ethris and Thermo Fisher team up to scale stable mRNA innovations and advance the SNIM RNA platform

they've attended our events

Image 1Image 2
Image 1Image 2
Image 1Image 2
Image 1Image 2

Expert Speakers

Dinesh Dhumal

CureVac SE

Nagy Habib

Imperial College London

Marco Mendez

AstraZeneca

Show more Speakers

Past Attendees

CureVac SE

Imperial College London

UCB

AstraZeneca

Alzchem Group

WuXi AppTec

BioNTech SE

TriLink Biotechnologies

Oxford Nanopore

Show more Attendees

hidden text

subscribe for updates

hidden text

our sponsors

arrow icon
4Basebio logo140527 - 500 px Logo with Tag,R_transparent-SmallBIA SeparationsEclipse Bio (1)
arrow icon

related events in the series